ES2425314R1 - Composición farmacéutica combinada y uso para preparar medicamentos destinados al tratamiento de trastornos del sistema genitourinario - Google Patents
Composición farmacéutica combinada y uso para preparar medicamentos destinados al tratamiento de trastornos del sistema genitourinario Download PDFInfo
- Publication number
- ES2425314R1 ES2425314R1 ES201390004A ES201390004A ES2425314R1 ES 2425314 R1 ES2425314 R1 ES 2425314R1 ES 201390004 A ES201390004 A ES 201390004A ES 201390004 A ES201390004 A ES 201390004A ES 2425314 R1 ES2425314 R1 ES 2425314R1
- Authority
- ES
- Spain
- Prior art keywords
- antibodies
- activated
- application
- homeopathic
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract 11
- 229940079593 drug Drugs 0.000 title claims abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract 4
- 208000035475 disorder Diseases 0.000 title claims abstract 4
- 210000002229 urogenital system Anatomy 0.000 title abstract 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 claims abstract 6
- 108010021487 Nitric Oxide Synthase Proteins 0.000 claims abstract 6
- 230000003511 endothelial effect Effects 0.000 claims abstract 6
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims abstract 5
- 208000010228 Erectile Dysfunction Diseases 0.000 claims abstract 5
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims abstract 5
- 201000001881 impotence Diseases 0.000 claims abstract 5
- 238000000034 method Methods 0.000 claims abstract 4
- 102000007066 Prostate-Specific Antigen Human genes 0.000 claims abstract 3
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims abstract 3
- 239000000203 mixture Substances 0.000 claims 10
- 230000001632 homeopathic effect Effects 0.000 claims 9
- 230000000694 effects Effects 0.000 claims 7
- 239000000902 placebo Substances 0.000 claims 6
- 229940068196 placebo Drugs 0.000 claims 6
- 208000013507 chronic prostatitis Diseases 0.000 claims 4
- 201000007094 prostatitis Diseases 0.000 claims 4
- 239000012895 dilution Substances 0.000 claims 3
- 238000010790 dilution Methods 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 230000007012 clinical effect Effects 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 241000408649 Cumbre Species 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 241000700159 Rattus Species 0.000 claims 1
- 238000013019 agitation Methods 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 102220240796 rs553605556 Human genes 0.000 claims 1
- 230000009329 sexual behaviour Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/303—Liver or Pancreas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010129294 | 2010-07-15 | ||
| RU2010129295 | 2010-07-15 | ||
| RU2010129295/15A RU2531049C2 (ru) | 2010-07-15 | 2010-07-15 | Лекарственное средство для лечения заболеваний предстательной железы и способ лечения заболеваний предстательной железы |
| RU2010129294/15A RU2542414C2 (ru) | 2010-07-15 | 2010-07-15 | Лекарственное средство для лечения эректильных дисфункций и способ лечения эректильных дисфункций |
| RU2011127053 | 2011-07-01 | ||
| RU2011127053/15A RU2565400C2 (ru) | 2011-07-01 | 2011-07-01 | Лекарственное средство для лечения заболеваний мочеполовой системы и способ лечения заболеваний мочеполовой системы |
| PCT/IB2011/002417 WO2012007849A2 (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2425314A2 ES2425314A2 (es) | 2013-10-14 |
| ES2425314R1 true ES2425314R1 (es) | 2014-07-09 |
Family
ID=44899158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201390004A Pending ES2425314R1 (es) | 2010-07-15 | 2011-07-15 | Composición farmacéutica combinada y uso para preparar medicamentos destinados al tratamiento de trastornos del sistema genitourinario |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20130064860A1 (enExample) |
| EP (1) | EP2593483A2 (enExample) |
| JP (3) | JP2013538791A (enExample) |
| CN (1) | CN103282384A (enExample) |
| AU (1) | AU2011278042B2 (enExample) |
| CA (1) | CA2805094A1 (enExample) |
| DE (1) | DE112011102350T5 (enExample) |
| EA (1) | EA029860B1 (enExample) |
| ES (1) | ES2425314R1 (enExample) |
| FR (1) | FR2962655A1 (enExample) |
| GB (1) | GB2495885B (enExample) |
| IT (1) | ITTO20110631A1 (enExample) |
| MX (1) | MX354187B (enExample) |
| MY (1) | MY165267A (enExample) |
| NZ (1) | NZ606775A (enExample) |
| SG (2) | SG10201505564VA (enExample) |
| WO (1) | WO2012007849A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| MX2013000543A (es) * | 2010-07-15 | 2013-10-28 | Oleg Iliich Epshtein | Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo. |
| FR2962652A1 (fr) | 2010-07-15 | 2012-01-20 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees a des maladies neurodegeneratives |
| PH12013500144A1 (en) | 2010-07-21 | 2018-03-21 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| FR2962909A1 (fr) | 2010-07-21 | 2012-01-27 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees avec une maladie ou affection respiratoire |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| CN110755599A (zh) * | 2013-10-23 | 2020-02-07 | 珍白斯凯尔有限公司 | 用于治疗和预防良性前列腺增生的组合物 |
| GB201513921D0 (en) * | 2015-08-05 | 2015-09-23 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1547611A1 (en) * | 2002-08-02 | 2005-06-29 | Oleg Iliich Epshtein | Medicinal agent and method for curing prostate diseases |
| EP1547612A1 (en) * | 2002-08-02 | 2005-06-29 | Oleg Iliich Epshtein | Medicinal agent and method for curing erectile dysfunction |
| US20100166762A1 (en) * | 2000-06-20 | 2010-07-01 | Oleg Iliich Epshtein | Method of treating a pathological syndrome |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| RU2197266C1 (ru) * | 2001-06-01 | 2003-01-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения эрозивных и воспалительных заболеваний желудочно-кишечного тракта |
| RU2001134982A (ru) * | 2001-12-26 | 2004-02-20 | Олег Ильич Эпштейн | Способ коррекции иммунного ответа и лекарственное средство |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| GB2414670B (en) | 2003-03-14 | 2008-03-19 | Nutrition Res Inc | Homeopathic formulations useful for treating pain and/or inflammation |
| CA2577613C (en) * | 2004-09-03 | 2015-12-15 | Chr. Hansen A/S | Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| MX2008012549A (es) * | 2006-04-04 | 2009-01-14 | Dong A Pharm Co Ltd | Agente para la prevencion y tratamiento de hiperplasia prostatica que comprende compuesto de pirazolopirimidinona. |
| RU2438707C2 (ru) * | 2006-06-06 | 2012-01-10 | Олег Ильич Эпштейн | Лекарственное средство для перорального лечения сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе, и способ получения твердой лекарственной формы для пероральной терапии сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе |
| CA2654408C (en) * | 2006-06-06 | 2018-05-08 | Oleg Iliich Epshtein | Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| KR100927958B1 (ko) * | 2006-07-13 | 2009-11-24 | 주식회사 머젠스 | 금속의 흡수를 촉진시키는 금속-산성아미노산 킬레이트를함유하는 조성물 |
| MX2013000543A (es) * | 2010-07-15 | 2013-10-28 | Oleg Iliich Epshtein | Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo. |
| EA029400B1 (ru) * | 2010-07-15 | 2018-03-30 | Олег Ильич ЭПШТЕЙН | Фармацевтическая композиция для лечения ожирения и сопутствующих метаболических расстройств и способ лечения |
| MY157564A (en) * | 2010-07-15 | 2016-06-30 | Epshtein Oleg Lliich | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
-
2011
- 2011-07-15 FR FR1156476A patent/FR2962655A1/fr not_active Withdrawn
- 2011-07-15 SG SG10201505564VA patent/SG10201505564VA/en unknown
- 2011-07-15 SG SG2013002308A patent/SG187036A1/en unknown
- 2011-07-15 MY MYPI2013000108A patent/MY165267A/en unknown
- 2011-07-15 MX MX2013000547A patent/MX354187B/es active IP Right Grant
- 2011-07-15 WO PCT/IB2011/002417 patent/WO2012007849A2/en not_active Ceased
- 2011-07-15 NZ NZ606775A patent/NZ606775A/en not_active IP Right Cessation
- 2011-07-15 GB GB1302651.3A patent/GB2495885B/en not_active Expired - Fee Related
- 2011-07-15 CA CA2805094A patent/CA2805094A1/en not_active Abandoned
- 2011-07-15 DE DE112011102350T patent/DE112011102350T5/de not_active Withdrawn
- 2011-07-15 AU AU2011278042A patent/AU2011278042B2/en not_active Ceased
- 2011-07-15 EP EP11784771.5A patent/EP2593483A2/en not_active Ceased
- 2011-07-15 JP JP2013519179A patent/JP2013538791A/ja active Pending
- 2011-07-15 CN CN201180044500XA patent/CN103282384A/zh active Pending
- 2011-07-15 IT IT000631A patent/ITTO20110631A1/it unknown
- 2011-07-15 US US13/135,898 patent/US20130064860A1/en not_active Abandoned
- 2011-07-15 ES ES201390004A patent/ES2425314R1/es active Pending
- 2011-07-15 EA EA201300129A patent/EA029860B1/ru not_active IP Right Cessation
-
2016
- 2016-07-01 JP JP2016131664A patent/JP2016199570A/ja active Pending
-
2018
- 2018-04-26 JP JP2018085388A patent/JP2018150322A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100166762A1 (en) * | 2000-06-20 | 2010-07-01 | Oleg Iliich Epshtein | Method of treating a pathological syndrome |
| EP1547611A1 (en) * | 2002-08-02 | 2005-06-29 | Oleg Iliich Epshtein | Medicinal agent and method for curing prostate diseases |
| EP1547612A1 (en) * | 2002-08-02 | 2005-06-29 | Oleg Iliich Epshtein | Medicinal agent and method for curing erectile dysfunction |
Non-Patent Citations (3)
| Title |
|---|
| Jonas W. B. et al. A critical overview of homeopathy. Ann. Intern. Med. 2003, Vol. 138, páginas 393-399 (todo el documento) * |
| Shang A. et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. The Lancet. 27.08.2005, Vol. 366, páginas 726-732 (todo el documento) * |
| Vickers A. J. et al. Clinical Trials of Homeopathy and Placebo: Analysis of a Scientific Debate. The Journal of Alternative and Complementary Medicine. 2000, Vol. 6, Nº 1, páginas 49-56 (todo el documento) * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011278042B2 (en) | 2017-02-16 |
| GB2495885B (en) | 2017-11-22 |
| AU2011278042A1 (en) | 2013-03-07 |
| JP2018150322A (ja) | 2018-09-27 |
| JP2016199570A (ja) | 2016-12-01 |
| FR2962655A1 (fr) | 2012-01-20 |
| ITTO20110631A1 (it) | 2012-01-16 |
| GB201302651D0 (en) | 2013-04-03 |
| MY165267A (en) | 2018-03-15 |
| WO2012007849A2 (en) | 2012-01-19 |
| CN103282384A (zh) | 2013-09-04 |
| EP2593483A2 (en) | 2013-05-22 |
| JP2013538791A (ja) | 2013-10-17 |
| EA029860B1 (ru) | 2018-05-31 |
| CA2805094A1 (en) | 2012-01-19 |
| DE112011102350T5 (de) | 2013-04-18 |
| SG187036A1 (en) | 2013-02-28 |
| NZ606775A (en) | 2015-08-28 |
| SG10201505564VA (en) | 2015-09-29 |
| MX2013000547A (es) | 2014-04-14 |
| WO2012007849A3 (en) | 2012-04-05 |
| ES2425314A2 (es) | 2013-10-14 |
| GB2495885A (en) | 2013-04-24 |
| US20130064860A1 (en) | 2013-03-14 |
| EA201300129A1 (ru) | 2013-12-30 |
| MX354187B (es) | 2018-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2425314R1 (es) | Composición farmacéutica combinada y uso para preparar medicamentos destinados al tratamiento de trastornos del sistema genitourinario | |
| ES2425004R1 (es) | Composición farmacéutica combinada y su uso para prerarar un medicamento destinado al tratamiento de las enfermedades o condiciones funcionales del tracto gastrointestinal | |
| Nelly et al. | Plants used as remedies antirheumatic and antineuralgic in the traditional medicine of Lebanon | |
| Hennings et al. | Illicit drugs: what dermatologists need to know | |
| GT199900203A (es) | Composiciones de celecoxib. | |
| AR073123A1 (es) | Composicion farmaceutica que comprende un taxano sustancialmente amorfo para utilizarse en el tratamiento de la enfermedad neoplasica | |
| AR033367A1 (es) | Derivados de imidazopirimidina y derivados de triazolopirimidina, un procedimiento para su preparacion, medicamentos, una composicion farmaceutica, y uso de dichos derivados para la preparacion de medicamentos | |
| AR062511A1 (es) | Formas de dosificacion farmaceutica | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| EA200700362A1 (ru) | Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью | |
| AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
| UY33515A (es) | Formulaciones estabilizadas que contienen anticuerpos anti-ngf | |
| MA35193B1 (fr) | Halogeno-alkyl-1,3 oxazines en tant qu'inhibiteurs de bace1 et/ou bace2 | |
| UY29410A1 (es) | Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones. | |
| AR068897A1 (es) | Inhibidores de proteasoma | |
| MA35748B1 (fr) | Fluorométhyl-5,6-dihydro-4h-[1,3]oxazines | |
| EA200501203A1 (ru) | Жидкие фармацевтические композиции палоносетрона | |
| EA200802020A1 (ru) | Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1 | |
| EA201591541A1 (ru) | Ингибиторы бета-секретазы 1 (bace 1) | |
| MX2012005689A (es) | Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos. | |
| UY28702A1 (es) | Derivados de quinazolina | |
| Nortey et al. | Herbs used in antimalarial medicines: A study in the Greater Accra Region of Ghana | |
| EA201490417A1 (ru) | Новые легкоразрушающиеся ингибиторы pde 4 | |
| BRPI1002067A8 (pt) | Formulação leishmanicida e seu uso | |
| DE602006016785D1 (de) | Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Grant refused |
Effective date: 20170828 |